Oral manganese for liver imaging at three different field strengths

Academic Radiology

Volumn 11, Issue 6, 2004, Pages 630-636

  Thomsen, Henrik S ^a   Loegager, Vibeke ^a   Noergaard, Henrik ^a   Chabanova, Elizaveta ^a   Moller, Jakob M ^a   Sonne, Jesper ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Contrast media; Gall bladder; Liver; Magnetic resonance imaging (MRI); Oral manganese

Indexed keywords

CMC 001; CONTRAST MEDIUM; MANGANESE CHLORIDE;

ADULT; ARTICLE; GALLBLADDER; HEPATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE QUALITY; LIVER; MALE; METALLIC TASTE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZATION; SIDE EFFECT; TASTE DISORDER;

EID: 2542483591     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2004.01.004     Document Type: Article

References (32)

1. Semelka RC, Helmberger TKG. Contrast agents for MR Imaging of the liver. Radiology 2001; 218:27-38.
2. Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R. MnDPDP-enhanced MRI vs dual phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol 2000; 10:1697-1702.
3. Gehl HB, Bourne M, Grazioli L, Möller A, Lodemann. Off-site evaluation of liver lesion detection by Gd-BOPTA-enhanced MR Imaging. Eur Radiol 2001; 11:181-192.
4. Mena I. Manganese. In: Bronner F, Cobum JW, eds. Disorders on mineral metabolism. New York, NY: Academic Press, 1981; 233-270.
5. Cotzias GC. Manganese in health and disease. Physiol Rev 1958; 38: 503-531.
6. Underwood EJ. Manganese. In: Underwood EJ, ed. Trace elements in human and animal nutrition. New York, NY: Academic Press, 1971; 177-207.
7. Keen CL, Lönnerdal B, Hurley LS. Manganese, In: Frieden J, ed. Biochemistry of the essential ultra-trace elements. New York, NY: Plenum Press, 1984; 89-132.
8. Korc M. Manganese homeostasis in humans and its role in disease states. In: Korc M, ed. Essential and toxic trace elements in human health and disease. New York, NY: Alan R. Liss, 1988; 253-273.
9. Kapoor V, Peterson MS, Baron RL, Patel S, Eghtesad B, Fung JJ. Intrahepatic biliary anatomy of living adult liver doners: correlation of mangafodipir trisodium-enhanced MR-cholangiography and intraoperative cholangiography. AJR Am J Roentgenol 2002; 179:1281-1286.
10. Thomsen HS, Svendsen O, Klastrup S. Increased manganese concentration in the liver after oral intake. Acad Radiol 2004; 11:38-44.
11. Garcia-Aranda JA, Wapnir RA, Lifshitz F. In vivo intestinal absorption of manganese in the rat. J Nutr 1983; 113:2601-2607.
12. Lutz TA, Schroff A, Scharrer E. Effects of calcium and sugars on intestinal manganese absorption. Biol Trace Elment Res 1993; 39:221-227.
13. Miller WJ. Dynamics of absorption rates, endogenous excretion, tissue turnover and homeostatic control mechanisms of zinc, cadmium, manganese, and nickel in ruminants. Fed Proc 1973; 32:1915-1920.
14. 2 and D3 in new world primates: influence on calcium absorption. Science 1967; 157:943-945.
15. Thomsen HS. Manganese containing magnetic resonance contrast agent. US Patent # 6,015,545/ January 18, 2000.
16. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991; 178:73-78.
17. Misselwitz B, Mühler A, Weinmann HJ. A toxicologic risk for using manganese complexes. A literature survey of existing data through several medical specialties. Invest Radiol 1995; 30:611-620.
18. Yu J-S, Kim M-J. Hepatocellular carcinoma: contrast-enhanced MRI. Abdom Imaging 2002; 27:157-167.
19. Laing ADP, Gibson RN. MRI of the liver. J Magn Reson Imaging 1998; 8:337-345.
20. Kim SK, Kim SH, Lee WJ, et al. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging. AJR Am J Roentgenol 2002; 179:741-750.
21. Mortele KJ, Wiesner W, de Hemptinne B, Elewaut A, Preaet M, Ros PR. Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings. Eur Radiol 2002; 12:304-308.
22. Wolf GL, Baum SL. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. AJR Am J Roentgenol 1983; 141:193-197.
23. Conrad LL, Trendly RL, Baxter DJ. Positive inotropic effect of manganese in dog myocardium. Am J Physiol 1966; 210:357-359.
24. Brurok H, Schøjtt J, Berg K, Karlsson JOG, Jynge P. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate-, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart. Invest Radiol 1995; 30:159-167.
25. Aschner M, Aschner JL. Manganese neurotoxicity; cellular effects and blood-brain barrier transport. Neurosci Behav Rev 1991; 15:333-340.
26. Keene JJ, Seidel CL, Bohr DF. Manganese on calcium flux and norepinephrine-induced tension in arterial smooth muscle. Proc Soc Exp Biol Med 1972; 139:1083-1085.
27. Conrad LL, Baxter DJ. Effects of manganese on Q-T interval and distribution of calcium in the rat heart. Am J Physiol 1963; 205:1209-1212.
28. Klaassen CD, Amdur MO, Doull J, eds. Casarett and Doull's The basic science of poisons 5th Edition. New York, NY: McGraw-Hill, 1995
29. Helmburger TK, Laubenberger J, Rummeny E, et al. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool. Eur Radiol 2002; 12:62-70.
30. Oudkerk M, Torres CG, König B, et al. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 2002; 223:517-524.
31. Kim KW, Park MS, Yu JS, et al. Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR-cholangiography: preliminary study. Radiology 2003; 227:580-584.
32. Vitellas KM, El-Dieb A, Vaswani KK, et al. Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients. AJR Am J Roentgenol 2002; 179:409-416.